Multilocus Sequence Typing of Candida tropicalis Shows the Presence of Different Clonal Clusters and Fluconazole Susceptibility Profiles in Sequential Isolates from Candidemia Patients in Sao Paulo, Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
21
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER SOC MICROBIOLOGY
Citação
JOURNAL OF CLINICAL MICROBIOLOGY, v.51, n.1, p.268-277, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The profiles of 61 Candida tropicalis isolates from 43 patients (28 adults and 15 children) diagnosed with candidemia at two teaching hospitals in Sao Paulo, Brazil, were characterized by multilocus sequence typing (MLST). For the 14 patients who had bloodstream infections, 32 isolates were serially collected from their blood and/or catheters. Thirty-nine diploid sequence types (DSTs) were differentiated. According to the C. tropicalis MLST database (http://pubmlst.org/ctropicalis/), 36 DSTs and 23 genotypes identified from the 61 isolates had not previously been described. This report represents the first study to characterize sequential isolates of C. tropicalis from candidemia cases in South America. Microvariation in a single gene was found in the sequential isolates from 7 patients. The main polymorphisms occurred in the alleles of the XYR1 gene, specifically at nucleotide positions 215, 242, and 344. Macrovariation in six gene fragments was detected in the isolates from 3 patients. eBURST analysis added two new groups to this study (groups 6 and 18). Additionally, susceptibility tests indicate that 3 isolates were resistant to fluconazole. No correlation was found between the DSTs and susceptibility to fluconazole and/or selective antifungal pressure. Two patients were sequentially infected with resistant and susceptible strains. MLST is an important tool for studying the genetic diversity of multiple/sequential isolates of patients with candidemia, allowing the comparison of our data with those from other regions of the world, as well as allowing an analysis of the genetic relationship among several clones in sequential isolates from the same or different candidemia patient sites (blood or catheter).
Palavras-chave
Referências
  1. AbiSaid D, 1997, CLIN INFECT DIS, V24, P1122
  2. Almirante B, 2005, J CLIN MICROBIOL, V43, P1829, DOI 10.1128/JCM.43.4.1829-1835.2005
  3. Bedini A, 2006, CLIN MICROBIOL INFEC, V12, P75, DOI 10.1111/j.1469-0691.2005.01310.x
  4. Bougnoux ME, 2002, J CLIN MICROBIOL, V40, P1290, DOI 10.1128/JCM.40.4.1290-1297.2002
  5. Bougnoux ME, 2008, INTENS CARE MED, V34, P292, DOI 10.1007/s00134-007-0865-y
  6. BUCHMAN TG, 1990, SURGERY, V108, P338
  7. Chakrabarti A, 2009, SCAND J INFECT DIS, V41, P275, DOI 10.1080/00365540902777105
  8. Chen KW, 2006, J CLIN MICROBIOL, V44, P2172, DOI 10.1128/JCM.00320-06
  9. Chen KW, 2009, INFECT GENET EVOL, V9, P912, DOI 10.1016/j.meegid.2009.06.011
  10. Chou HH, 2007, DIAGN MICR INFEC DIS, V58, P427, DOI 10.1016/j.diagmicrobio.2007.03.014
  11. Clinical and Laboratory Standards Institute, 2008, M27A3 CLSI
  12. Colombo AL, 2006, J CLIN MICROBIOL, V44, P2816, DOI 10.1128/JCM.00773-06
  13. Costa SF, 2000, J HOSP INFECT, V45, P69, DOI 10.1053/jhin.1999.0670
  14. Da Matta DA, 2010, MED MYCOL, V48, P757, DOI 10.3109/13693780903501689
  15. da Matta DA, 2007, DIAGN MICR INFEC DIS, V57, P399, DOI 10.1016/j.diagmicrobio.2006.10.011
  16. Ewing B, 1998, GENOME RES, V8, P175
  17. Ewing B, 1998, GENOME RES, V8, P186
  18. Falagas ME, 2010, INT J INFECT DIS, V14, P954
  19. FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678
  20. FRASER VJ, 1992, CLIN INFECT DIS, V15, P414
  21. Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745
  22. Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039
  23. HUNTER PR, 1989, J CLIN MICROBIOL, V27, P2156
  24. HUNTER PR, 1990, J CLIN MICROBIOL, V28, P1903
  25. Jacobsen MD, 2008, MED MYCOL, V46, P647, DOI 10.1080/13693780801986631
  26. Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86
  27. Kontoyiannis DP, 2001, CLIN INFECT DIS, V33, P1676, DOI 10.1086/323812
  28. Leroy O, 2009, CRIT CARE MED, V37, P1612, DOI 10.1097/CCM.0b013e31819efac0
  29. Li SY, 2009, MICROB DRUG RESIST, V15, P205, DOI 10.1089/mdr.2009.0915
  30. Lin CY, 2007, J CLIN MICROBIOL, V45, P2452, DOI 10.1128/JCM.00699-07
  31. Lott TJ, 2012, MED MYCOL, V50, P136, DOI 10.3109/13693786.2011.592153
  32. Morgan J, 2005, INFECT CONT HOSP EP, V26, P540, DOI 10.1086/502581
  33. Motta AL, 2010, BRAZ J INFECT DIS, V14, P441, DOI 10.1590/S1413-86702010000500004
  34. Munoz P, 2011, CLIN MICROBIOL INFEC, V17, P1538, DOI 10.1111/j.1469-0691.2010.03338.x
  35. Myoken Y, 2004, HAEMATOLOGICA, V89, P378
  36. National Committee for Clinical Laboratory Standards, 2002, M27A2 NCCLS
  37. Nucci M, 2007, DIAGN MICR INFEC DIS, V58, P77, DOI 10.1016/j.diagmicrobio.2006.11.009
  38. Odds FC, 2008, EUKARYOT CELL, V7, P1075, DOI 10.1128/EC.00062-08
  39. Odds FC, 2007, J MED MICROBIOL, V56, P1066, DOI 10.1099/jmm.0.47239-0
  40. Odds FC, 2006, J CLIN MICROBIOL, V44, P3647, DOI 10.1128/JCM.00934-06
  41. Pfaller MA, 1998, DIAGN MICR INFEC DIS, V30, P121, DOI 10.1016/S0732-8893(97)00192-2
  42. Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09
  43. Rentz AM, 1998, CLIN INFECT DIS, V27, P781, DOI 10.1086/514955
  44. Sheng WH, 2005, J HOSP INFECT, V59, P205, DOI 10.1016/j.jhin.2004.06.003
  45. Shin JH, 2007, J CLIN MICROBIOL, V45, P2385, DOI 10.1128/JCM.00381-07
  46. Sipsas NV, 2009, CANCER, V115, P4745, DOI 10.1002/cncr.24507
  47. Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
  48. TAMURA K, 1993, MOL BIOL EVOL, V10, P512
  49. Tavanti A, 2005, J CLIN MICROBIOL, V43, P5593, DOI 10.1128/JCM.43.11.5593-5600.2005
  50. Vigouroux S, 2006, HAEMATOL-HEMATOL J, V91, P717
  51. Viscoli C, 1999, CLIN INFECT DIS, V28, P1071, DOI 10.1086/514731
  52. Voss A, 1996, EUR J CLIN MICROBIOL, V15, P909, DOI 10.1007/BF01690507